Current Edition

Upcoming Events


Volume 4 Issue 4

Understanding the Role of Regulatory T Cells in Breast Cancer Metastasis

Breast cancer is the most common cancer amongst women accounting for 24 percent of new cancer cases worldwide and 15 percent of cancer deaths in 2018. While survival ...
Continue Reading →

Lilly drug cleared by FDA for wider use in breast cancer

The new label opens up a significant market opportunity for Lilly, as about 70% of people diagnosed with breast cancer have the hormone receptor positive, HER-2 negat...
Continue Reading →